Home › Overweight › Texas › Amarillo
Overweight clinical trials in Amarillo, TX
7 studies for Overweight are looking for participants at sites in and around Amarillo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 2
- Amarillo Medical Specialists /ID# 282380, Amarillo
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RecruitingPhase 3
- Amarillo Medical Specialists, Amarillo
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
- Amarillo Med Spec LLP, Amarillo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- PharmaTex Research, LLC, Amarillo
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RecruitingPhase 3
- Kailera Clinical Site, Amarillo
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RecruitingPhase 3
- Kailera Clinical Site, Amarillo
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
RecruitingPhase 1
- Amarillo Medical Specialists, Amarillo
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Amarillo
- Obesity10 studies
- Heart Failure8 studies
- Non-Small Cell Lung Cancer8 studies
- Atherosclerosis6 studies
- Lung Cancer5 studies
- Cardiovascular Disease5 studies
- Blood Clots4 studies
- Breast Cancer3 studies
- Colorectal Cancer3 studies
- Digestive Diseases3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.